Trade LGVN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Longeveron Inc. Class A (LGVN) is trading at US$2.43, down 0.94% today as of Sep 22, 10:36 EDT. The company has a market capitalisation of US$26.94M. Over the past 52 weeks, LGVN has traded between US$2.30 and US$12.30. On Syfe you can trade LGVN with $0 commission and add it to your watchlist.
| Previous close | US$2.45 |
|---|---|
| Market cap | US$26.94M |
| 52-week range | US$2.30 – US$12.30 |
| Volume | 170.87K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Longeveron Inc. Class A
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Year: 2021
Longeveron Appoints Nirav Jhaveri As CFO
Aug 19, 8:16 PM · MT Newswires
Longeveron Names Marie Washburn as CFO
Jul 6, 8:24 PM · MT Newswires
Longeveron Inc. Class A (LGVN) stock is trading at US$2.43, -0.94% from the previous close of US$2.45.
The market cap for Longeveron Inc. Class A (LGVN) stock is approximately US$26.94M.
The 52-week high for Longeveron Inc. Class A (LGVN) stock is US$12.30.
The 52-week low for Longeveron Inc. Class A (LGVN) stock is US$2.30.
Longeveron Inc. Class A (LGVN) does not currently pay a dividend.
Stay on top of LGVN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
